AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Learn which fund family offers the best Sharpe ratio indices and why it matters for risk-adjusted performance. Compare funds to identify strong performers.
28,055 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Pi Network's PI token fell about 4% this week, failing to hold above $0.13 as bears press the crucial support. The mo...
Micron Technology sparked a broad tech rally after investors moved past AI-bearish sentiment, lifting major indices a...
AmeriCraft Homes, backed by veteran developer Art Falcone, launches a Southeast expansion focused on attainable luxur...
New analysis challenges the panic around RMDs for average savers. For a 62-year-old with a typical IRA balance, the f...
Carnival sailed to another quarter of record yields, yet its shares lag Royal Caribbean as debt, pricing power, and c...
Is the clock ticking gamestop stock? A practical, not-panic guide for investors weighing whether GameStop can pivot f...
Ethereum tests a critical barrier near $1,800 as traders watch for a breakout that could unlock a rally toward $2,000...
Pi Network unveils a July upgrade featuring AI-assisted planning and persistent data across sessions, while the nativ...
Mortgage lenders are moving AI from experimentation to enterprise deployment in 2026. Addy AI's Michael Vandi explain...
Ethereum climbs past $1,900 as Arthur Hayes makes a fresh ETH buy, renewing debate about his trading approach and the...
FTX launches a $900 million creditor payout on July 31 to eligible holders, while 45 jurisdictions remain blocked fro...